Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 42%
Sell 8%
Strong Sell 0%

Bulls say

Henry Schein Inc. has demonstrated solid revenue growth across its key segments, with medical products revenue increasing by 4.7% as reported and 3.0% on a local internal basis, accompanied by noticeable growth in the dental sector, where revenue rose by 5.5% on both reported and local internal metrics. Additionally, the global technology segment showed significant performance, generating $173 million in revenue and growing by 9.7% as reported, indicating a strong demand for technology solutions within the healthcare space. The company anticipates adjusted EBITDA to grow in the mid-single digits for 2025 compared to FY/24, reflecting ongoing operational resilience and strategic value creation.

Bears say

Henry Schein Inc. reported gross margins that consistently fell short of expectations, with figures of 30.9% and 30.7% for the recent quarters, indicating challenges in maintaining profitability. Additionally, the company anticipates lower remeasurement gains in 2026 compared to 2025, which poses potential risks to future earnings, exacerbated by an unfavorable product mix in its distribution and specialty products segments. Although M&A and foreign currency effects provided modest tailwinds, these factors may not be sufficient to offset the underlying operational difficulties contributing to the negative outlook on the company’s stock.

Henry Schein (HSIC) has been analyzed by 12 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 42% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 12 analysts, Henry Schein (HSIC) has a Hold consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.